Investor insights
Sectors invested in
Funding rounds participated in
$76M sweet spot round size
Most of their 24 investments are in rounds between $38M and $110M
Investor type
Basic info
Industry
Sectors
Date founded
2006
Investments made
Crisp raised $35M on February 2, 2022
Investors: Spring Capital, Tapas Capital and Ridgeback Capital Management LLC
Freenome raised $300M on December 7, 2021
Investors: Suvretta Capital Management LLC, Pura Vida Investments, Soleus Capital Management, L.P., Section 32, RA Capital Management, L.P., Sands Capital Management, T. Rowe Price and Ridgeback Capital Management LLC
Quell Therapeutics raised $156M on November 29, 2021
Investors: SV Life Sciences, Tekla Capital Management, Syncona Limited, Monashee Investment Management LLC, JEITO, British Patient Capital, Point72 Asset Management and Ridgeback Capital Management LLC
Arbor Biotechnologies raised $215M on November 9, 2021
Investors: TCG X, Tao Capital Partners, Surveyor Capital, Tekla Capital Management, T. Rowe Price, Section 32, Vertex Pharmaceuticals, Temasek, Woodline Partners LP and Ridgeback Capital Management LLC
Garuda Therapeutics raised $72M on September 23, 2021
Investors: Aisling Capital, Sectoral Asset Management, Tatleaux Partners, LLC, Northpond Ventures, Monashee Investment Management LLC, OrbiMed Advisors and Ridgeback Capital Management LLC
Turnstone Biologics raised $80M on July 14, 2021
Investors: Partner Fund Management, Sectoral Asset Management, Takeda UK Limited, OrbiMed Advisors, Point72 Asset Management, Teralys Capital, Surveyor Capital, Versant Ventures, Sixty Degree Capital and Ridgeback Capital Management LLC
Pyxis Oncology raised $152M on March 30, 2021
Investors: Leaps by Bayer, LifeSci Venture Partners, Tekla Capital Management, Logos Global Management, LP, RTW Investments, LP, Surveyor Capital, Perceptive Advisors, Longwood Fund and Ridgeback Capital Management LLC
Caribou Biosciences raised $115M on March 3, 2021
Investors: Maverick Ventures, Partner Fund Management, Monashee Investment Management LLC, Tekla Capital Management, The Leukemia & Lymphoma Society, Point72 Ventures, LifeSci Venture Partners, Mission BioCapital and Ridgeback Capital Management LLC
Viracta Therapeutics, Inc. raised $65M on February 24, 2021
Investors: Sectoral Asset Management, aMoon Fund, Logos Global Management, LP, LifeSci Venture Partners, Surveyor Capital, Samsara BioCapital and Ridgeback Capital Management LLC
- raised $175M on February 16, 2021
Investors: Eldridge, UPMC Enterprises, Wellington Management and Ridgeback Capital Management LLC